RxDoctor Payments DataLook up a doctor →

Hoshedar Tamboli, MD

Cardiovascular Disease · Brandon, FLNPI 1629030127

Payments from drug & device makers

$871,468in general payments, 2019–2025

Across 74 payments — averaging $11,777 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$865K
  • Abbott$3K
  • Penumbra, Inc.$1K
  • Kestra Medical Technology Services, Inc.$421
  • Ancora Heart, Inc.$416
  • Shockwave Medical, Inc$317
  • plus $1K from 14 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$871,468 in reported general payments places this provider in the 95th percentile of 1,740 cardiovascular disease providers in Florida.

See all cardiovascular disease providers in Florida

Medicare billing

Part B allowed, 2024
$813,242
Medicare patients
1,994
Services billed
7,748

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Brandon

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →